Omics-driven networks herald a new era of multidimensional therapy for cholangiocarcinoma.
作者信息
Liu Yuming, Wang Ganggang, Gao Qiang
机构信息
Department of Hepatic Oncology, Shanghai Geriatric Medical Center, Fudan University, Shanghai, China.
Department of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Zhongshan Hospital, Fudan University, Shanghai, China.
出版信息
Hepatol Commun. 2025 Sep 5;9(9). doi: 10.1097/HC9.0000000000000809. eCollection 2025 Sep 1.
Abstract
摘要
相似文献
1
Omics-driven networks herald a new era of multidimensional therapy for cholangiocarcinoma.
Hepatol Commun. 2025 Sep 5;9(9). doi: 10.1097/HC9.0000000000000809. eCollection 2025 Sep 1.
2
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.
J Transl Med. 2025 Jul 25;23(1):837. doi: 10.1186/s12967-025-06856-x.
3
Graph neural networks for single-cell omics data: a review of approaches and applications.
Brief Bioinform. 2025 Mar 4;26(2). doi: 10.1093/bib/bbaf109.
4
Monitoring miR-29a for targeted therapy of cholangiocarcinoma based on a photoelectric sensor.
Mikrochim Acta. 2025 Aug 14;192(9):592. doi: 10.1007/s00604-025-07424-2.
5
Multi-omics: a bridge connecting genotype and phenotype for epilepsy?
Biomark Res. 2025 Jun 18;13(1):86. doi: 10.1186/s40364-025-00798-8.
6
Multi-omics approaches for identifying the PANoptosis signature and prognostic model via a multimachine-learning computational framework for intrahepatic cholangiocarcinoma.
Hepatology. 2025 Apr 15. doi: 10.1097/HEP.0000000000001352.
7
Living Donor Liver Transplantation for Neoadjuvant-Treated, Unresectable Intrahepatic Cholangiocarcinoma (LIVINCA): Study Protocol for a One-Armed, Monocentric, Non-Randomized Trial.
Oncol Res Treat. 2025;48(9):514-523. doi: 10.1159/000545871. Epub 2025 Apr 14.
8
MGDMCL: A multi-omics integration framework based on masked graph dynamic learning and multi-granularity feature contrastive learning for biomedical classification.
Comput Methods Programs Biomed. 2025 Nov;271:109024. doi: 10.1016/j.cmpb.2025.109024. Epub 2025 Aug 13.
9
Artificial Intelligence and Multi-Omics in Pharmacogenomics: A New Era of Precision Medicine.
Mayo Clin Proc Digit Health. 2025 Jun 26;3(3):100246. doi: 10.1016/j.mcpdig.2025.100246. eCollection 2025 Sep.
10
Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD012814. doi: 10.1002/14651858.CD012814.pub2.
本文引用的文献
1
The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers.
Cancer Treat Rev. 2025 Jun;137:102955. doi: 10.1016/j.ctrv.2025.102955. Epub 2025 May 9.
2
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.
Cancer Discov. 2025 Jun 3;15(6):1129-1140. doi: 10.1158/2159-8290.CD-24-1726.
3
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.
Hepatol Commun. 2025 Feb 19;9(3). doi: 10.1097/HC9.0000000000000632. eCollection 2025 Mar 1.
4
Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma.
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000597. eCollection 2025 Jan 1.
5
Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers.
Cancer Res. 2024 Jun 4;84(11):1747-1763. doi: 10.1158/0008-5472.CAN-23-3298.
6
Macro CD5L deteriorates CD8T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Nat Commun. 2024 Jan 20;15(1):621. doi: 10.1038/s41467-024-44795-1.
7
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.
J Natl Cancer Inst. 2023 Jul 6;115(7):870-880. doi: 10.1093/jnci/djad046.
8
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.
Cancer Discov. 2022 Mar 1;12(3):812-835. doi: 10.1158/2159-8290.CD-21-1077.
9
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.
Mol Cancer. 2021 Mar 8;20(1):50. doi: 10.1186/s12943-021-01342-6.
10
Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers.
Clin Cancer Res. 2018 Mar 15;24(6):1277-1286. doi: 10.1158/1078-0432.CCR-17-0432. Epub 2017 Nov 14.
Zotero 插件